Your browser doesn't support javascript.
loading
Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases.
Zhang, Xiaoli; Zhao, Yalei; Liu, Liangru; He, Yingli.
Affiliation
  • Zhang X; Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhao Y; National Regional Infectious Diseases Center Co-constructed by National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, China.
  • Liu L; Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • He Y; National Regional Infectious Diseases Center Co-constructed by National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, China.
Curr Drug Targets ; 24(15): 1155-1165, 2023.
Article in En | MEDLINE | ID: mdl-37957867
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Syndecan-1 / Liver Neoplasms Limits: Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: China Country of publication: Emiratos Árabes Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Syndecan-1 / Liver Neoplasms Limits: Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: China Country of publication: Emiratos Árabes Unidos